Global Wealth Management Investment Advisory’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-48
Closed -$3K 579
2020
Q2
$3K Hold
48
﹤0.01% 487
2020
Q1
$3K Hold
48
﹤0.01% 480
2019
Q4
$3K Hold
48
﹤0.01% 490
2019
Q3
$3K Hold
48
﹤0.01% 468
2019
Q2
$3K Hold
48
﹤0.01% 510
2019
Q1
$3K Sell
48
-7
-13% -$460 ﹤0.01% 505
2018
Q4
$3K Buy
+55
New +$3.71K ﹤0.01% 544

Other funds holding PJP

Global Wealth Management Investment Advisory's PJP Position: Q3 2020 in Review

Global Wealth Management Investment Advisory sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2020, closing a stake of 48 shares — an estimated $3K sold.

Global Wealth Management Investment Advisory first reported a position in PJP in Q4 2018 and held it in 7 quarters. The position peaked at $3K in Q2 2020. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2020.

  • Global Wealth Management Investment Advisory reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 48 Invesco Pharmaceuticals ETF shares in Q3 2020, an estimated $3K.
  • Global Wealth Management Investment Advisory first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 7 quarters.
  • Global Wealth Management Investment Advisory's Invesco Pharmaceuticals ETF position peaked at $3K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.